Solasonine/solamargine

N/A

Report date: 2024/12/02 11:06:07

Base Information

Drug NameSolasonine/solamargine
Drug Alias NameCuraderm BEC5SBP-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIL-6 receptor antagonists
TargetsIL-6 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryOman
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSolbec Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSultan Qaboos University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A